Felder ER - Search Results

1

Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structures.

Klimkait T, Felder ER, Albrecht G, Hamy F. Klimkait T, et al. Among authors: felder er. Biotechnol Bioeng. 1998-1999;61(3):155-68. doi: 10.1002/(sici)1097-0290(1998)61:3<155::aid-cc3>3.0.co;2-g. Biotechnol Bioeng. 1998. PMID: 10397803

2

Merged screening for human immunodeficiency virus Tat and Rev inhibitors.

Hamy F, Felder E, Lipson K, Klimkait T. Hamy F, et al. J Biomol Screen. 2001 Jun;6(3):179-87. doi: 10.1177/108705710100600308. J Biomol Screen. 2001. PMID: 11689114

3

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.

Hamy F, Felder ER, Heizmann G, Lazdins J, Aboul-ela F, Varani G, Karn J, Klimkait T. Hamy F, et al. Among authors: felder er. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3548-53. doi: 10.1073/pnas.94.8.3548. Proc Natl Acad Sci U S A. 1997. PMID: 9108013 Free PMC article.

4

Synthesis of an N-3-guanidinopropylglycine (Narg) derivative as a versatile building block for solid-phase peptide and peptoid synthesis.

Heizmann G, Felder ER. Heizmann G, et al. Among authors: felder er. Pept Res. 1994 Nov-Dec;7(6):328-32. Pept Res. 1994. PMID: 7888715

5

Key Intermediates in Combinatorial Chemistry: Access to Various Heterocycles from alpha,beta-Unsaturated Ketones on the Solid Phase.

Marzinzik AL, Felder ER. Marzinzik AL, et al. Among authors: felder er. J Org Chem. 1998 Feb 6;63(3):723-727. doi: 10.1021/jo971620u. J Org Chem. 1998. PMID: 11672066

6

A new combination of protecting groups and links for encoded synthetic libraries suited for consecutive tests on the solid phase and in solution.

Felder ER, Heizmann G, Matthews IT, Rink H, Spieser E. Felder ER, et al. Mol Divers. 1996 Feb;1(2):109-12. doi: 10.1007/BF01721325. Mol Divers. 1996. PMID: 9237199

7

Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells.

Cumin F, Asselbergs F, Lartigot M, Felder E. Cumin F, et al. Eur J Biochem. 1993 Mar 1;212(2):347-54. doi: 10.1111/j.1432-1033.1993.tb17668.x. Eur J Biochem. 1993. PMID: 8444172 Free article.

8

14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. I. Synthesis and biological activity.

Said-Nejad OE, Felder ER, Mierke DF, Yamazaki T, Schiller PW, Goodman M. Said-Nejad OE, et al. Among authors: felder er. Int J Pept Protein Res. 1992 Feb;39(2):145-60. doi: 10.1111/j.1399-3011.1992.tb00784.x. Int J Pept Protein Res. 1992. PMID: 1517014

9

14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.

Yamazaki T, Mierke DF, Said-Nejad OE, Felder ER, Goodman M. Yamazaki T, et al. Among authors: felder er. Int J Pept Protein Res. 1992 Feb;39(2):161-81. doi: 10.1111/j.1399-3011.1992.tb00785.x. Int J Pept Protein Res. 1992. PMID: 1517015

10

Peptidomimetic opioids--synthesis, spectroscopy, and computer simulations.

Goodman M, Sald-Nejad OE, Felder E, Mierke DF, Yamazaki T, Schiller PW. Goodman M, et al. NIDA Res Monogr. 1991;112:218-38. NIDA Res Monogr. 1991. PMID: 1754000 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters